HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hypersplenism (Anemia, Splenic)

Condition characterized by splenomegaly, some reduction in the number of circulating blood cells in the presence of a normal or hyperactive bone marrow, and the potential for reversal by splenectomy.
Also Known As:
Anemia, Splenic; Anemias, Splenic; Splenic Anemia; Splenic Anemias
Networked: 735 relevant articles (57 outcomes, 57 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Thrombocytopenia (Thrombopenia)
2. Hemorrhage
3. Portal Hypertension
4. Liver Cirrhosis (Hepatic Cirrhosis)
5. Hepatocellular Carcinoma (Hepatoma)

Experts

1. Maehara, Yoshihiko: 11 articles (07/2015 - 05/2004)
2. Tomikawa, Morimasa: 10 articles (03/2013 - 01/2002)
3. Akahoshi, Tomohiko: 9 articles (03/2013 - 01/2009)
4. Kawanaka, Hirofumi: 8 articles (07/2015 - 01/2009)
5. Al-Salem, Ahmed H: 5 articles (01/2016 - 10/2002)
6. Ikegami, Toru: 5 articles (07/2015 - 12/2008)
7. Hashimoto, Naotaka: 5 articles (10/2012 - 01/2009)
8. Uehara, Hideo: 5 articles (10/2012 - 01/2009)
9. Kinjo, Nao: 5 articles (02/2012 - 01/2009)
10. Takenaka, Kenji: 5 articles (03/2010 - 11/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hypersplenism:
1. InterferonsIBA
2. Inosine Triphosphate (ITP)IBA
3. AntibodiesIBA
4. Granulocyte Colony-Stimulating Factor (G-CSF)IBA
5. CholesterolIBA
6. SiliconesIBA
7. Immunoglobulin M (IgM)IBA
8. Lysergic Acid Diethylamide (LSD)IBA
9. CreatinineIBA
10. CopperIBA

Therapies and Procedures

1. Splenectomy
2. Ligation
3. Hepatectomy
4. Liver Transplantation
5. Surgical Splenorenal Shunt (Splenorenal Shunt)